cyclopentane has been researched along with mdl 100907 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kłodzińska, A; Neuville, P; Palucha-Poniewiera, A; Pilc, A; Schann, S; Stachowicz, K | 1 |
1 other study(ies) available for cyclopentane and mdl 100907
Article | Year |
---|---|
The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Cyclopentanes; Depression; Flumazenil; GABA-A Receptor Antagonists; gamma-Aminobutyric Acid; Injections, Intraperitoneal; Male; Piperazines; Pyridines; Rats; Rats, Wistar; Receptors, Metabotropic Glutamate; Ritanserin; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Stress, Psychological; Tricarboxylic Acids | 2009 |